Nature

Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer

The low probability of curing high-risk prostate cancer (PC) with local therapy suggests the need to study modality of therapeutic approaches. To this end, a prospective phase II trial of neoadjuvant ...
Healio

Testosterone provides safe estrogen alternative for women with complete androgen insensitivity syndrome

Please provide your email address to receive an email when new articles are posted on . Women with complete androgen insensitivity syndrome randomly assigned to receive daily testosterone therapy for ...
Medscape

Estradiol, Testosterone Trigger Dyslipidemia in Women With Complete Androgen Insensitivity

This study was published in ResearchSquare.com as a preprint and has not yet been peer reviewed. Treatment of patients with CAIS with either estradiol or testosterone also led to a small but ...
Healio

Gonadectomy fails to affect BMD in complete androgen insensitivity syndrome

Please provide your email address to receive an email when new articles are posted on . Women with complete androgen insensitivity syndrome have decreased bone mineral density at the lumbar spine and ...
Medscape

Complete Androgen Insensitivity Syndrome

Previously referred to as testicular feminization, this condition is known as complete androgen insensitivity syndrome. It is an X-linked disorder in which the patients are genotypically male ...
ascopubs.org

Complete androgen blockade as second-line hormone manipulation and delay of chemotherapy in metastatic prostate cancer

Staging with 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) for nonseminomatous germ cell tumor (NSGCT): The Peter MacCallum Cancer Centre experience No significant financial ...